Service and Product Launches in 2020 Q1

2020年03月31日

The OATP1B1 assay was fully characterized with a clinically relevant substrate and newly added to our portfolio.

The OATP1B3 assay was fully characterized with a clinically relevant substrate and newly added to our portfolio.

The Caco-2 assay was set-up for testing MRP2 substrate CDCF-DA, confirming this Caco-2 clone has activity of MRP2.